TRIM5α, TRIM56 and TRIM69 differentially regulate dengue virus 2 infection through selective NS2B3-mediated antagonism

Dengue virus (DENV) is a major mosquito-borne human pathogen. Understanding the mechanisms of cellular resistance to the infection is vital to develop novel therapeutic tools. Tripartite motif (TRIM) proteins contribute to antiviral innate immunity through direct restriction of viral replication and regulation of antiviral signaling, but current knowledge on DENV targeting by TRIM proteins remains preliminary. Previously, TRIM56 was found to inhibit DENV, whereas reports on whether TRIM69 is a DENV restriction factor are conflicting. Surprisingly, the broad-spectrum viral restriction factor TRIM5α was proposed to restrict tick-borne but not mosquito-borne flaviviruses. Here, we investigated the effects of TRIM5α, TRIM56, and TRIM69 on DENV serotype 2 (DENV2) infection. Overexpression experiments showed that TRIM5α and TRIM56 restrict DENV2, whereas TRIM69 enhances it. Consistently, CRISPR/Cas9-mediated loss-of-function showed that knocking out TRIM5α or TRIM56 increases infection, while TRIM69 knockout decreases it. Restriction correlated with reduced viral RNA and viral protein levels in TRIM5α- and TRIM56-expressing cells. Virus-free experiments showed that TRIM56 downregulates the DENV2 protease complex NS2B3 levels. Reciprocally, DENV2 NS2B3 reduced TRIM56 and TRIM69 abundance independently of protease activity. RING domain-mutated TRIM56 retained partial antiviral activity and the ability to reduce NS2B3 levels, and TRIM56-NS2B3 reciprocal downmodulation effects were not counteracted by proteasomal or lysosomal inhibition. Together, these findings establish TRIM5α as a DENV2 restriction factor, reveal TRIM69 as a positive factor in DENV2 infection, suggest that TRIM5? and TRIM56 inhibit DENV2 through distinct mechanisms, and hint at proteasome-independent TRIM56-NS2B3 reciprocal downmodulation.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.16.767120
Primary Topic
Mosquito-borne diseases and control
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

TRIM5α, TRIM56 and TRIM69 differentially regulate dengue virus 2 infection through selective NS2B3-mediated antagonism

Laurent Chatel‐Chaix, Isabel Desgagné‐Penix, Luan Letieri Belem Martins, Ricky Raj Paswan et al.
bioRxiv (Cold Spring Harbor Laboratory)
Mosquito-borne diseases and control
preprint

TRIM5α, TRIM56 and TRIM69 differentially regulate dengue virus 2 infection through selective NS2B3-mediated antagonism

Laurent Chatel‐Chaix, Isabel Desgagné‐Penix, Luan Letieri Belem Martins, Ricky Raj Paswan, Lionel Berthoux, Natacha Mérindol, Nguyễn Hà Nhung, Aïssatou Aïcha Sow, Soléna Rossi, Jyotika Singh
preprint en

Abstract

Dengue virus (DENV) is a major mosquito-borne human pathogen. Understanding the mechanisms of cellular resistance to the infection is vital to develop novel therapeutic tools. Tripartite motif (TRIM) proteins contribute to antiviral innate immunity through direct restriction of viral replication and regulation of antiviral signaling, but current knowledge on DENV targeting by TRIM proteins remains preliminary. Previously, TRIM56 was found to inhibit DENV, whereas reports on whether TRIM69 is a DENV restriction factor are conflicting. Surprisingly, the broad-spectrum viral restriction factor TRIM5α was proposed to restrict tick-borne but not mosquito-borne flaviviruses. Here, we investigated the effects of TRIM5α, TRIM56, and TRIM69 on DENV serotype 2 (DENV2) infection. Overexpression experiments showed that TRIM5α and TRIM56 restrict DENV2, whereas TRIM69 enhances it. Consistently, CRISPR/Cas9-mediated loss-of-function showed that knocking out TRIM5α or TRIM56 increases infection, while TRIM69 knockout decreases it. Restriction correlated with reduced viral RNA and viral protein levels in TRIM5α- and TRIM56-expressing cells. Virus-free experiments showed that TRIM56 downregulates the DENV2 protease complex NS2B3 levels. Reciprocally, DENV2 NS2B3 reduced TRIM56 and TRIM69 abundance independently of protease activity. RING domain-mutated TRIM56 retained partial antiviral activity and the ability to reduce NS2B3 levels, and TRIM56-NS2B3 reciprocal downmodulation effects were not counteracted by proteasomal or lysosomal inhibition. Together, these findings establish TRIM5α as a DENV2 restriction factor, reveal TRIM69 as a positive factor in DENV2 infection, suggest that TRIM5? and TRIM56 inhibit DENV2 through distinct mechanisms, and hint at proteasome-independent TRIM56-NS2B3 reciprocal downmodulation.

bioRxiv (Cold Spring Harbor Laboratory)
Institut Pasteur (FR), Institut National de la Recherche Scientifique (CA), Institut de Virologie (FR), Centre Armand-Frappier Santé Biotechnologie (CA), Université du Québec à Trois-Rivières (CA)
Good health and well-being
Mosquito-borne diseases and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon